Our Approach
The recent increase in Powassan cases—and the potential for infection to cause serious symptoms—has led scientists at La Jolla Institute for Immunology (LJI) to launch new research into how the immune system combats the virus.
LJI Professor Sujan Shresta, Ph.D., is leading research into how the immune system’s T cells respond to Powassan virus. Dr. Shresta is an expert in how T cells interact with flaviviruses, and her research has led to new vaccine strategies against dengue virus and Zika virus. By studying Powassan virus, Dr. Shresta and her colleagues hope to move closer to developing a “pan-flavivirus” vaccine against members of this viral family.
LJI Professor Alessandro Sette, Dr.Biol.Sci., and LJI Research Assistant Professor Alba Grifoni, Ph.D., also recently received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), to investigate how T cells recognize viral targets, or “epitopes, on many kinds of mosquito and tick-borne “arboviruses,” including Powassan virus.